SkinBioTherapeutics Plc (SBTX.L)
GBp 19.25
(-0.65%)
GBp 19.25
(-0.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 132.05 Thousand | 74.76 Thousand | - | - | - | - |
| Cost of Revenue | 46.86 Thousand | 58.84 Thousand | 5055.00 | 5100.00 | 3400.00 | - |
| Gross Profit | 85.19 Thousand | 15.91 Thousand | -5055.00 | -5100.00 | -3400.00 | - |
| Operating Expenses | 3.08 Million | 2.99 Million | 1.48 Million | 1.61 Million | 1.35 Million | 941.19 Thousand |
| Selling, General and Administrative Expenses | 2.15 Million | 2.13 Million | 983.67 Thousand | 979.71 Thousand | 647.29 Thousand | 525.28 Thousand |
| Research and Development Expenses | 930.63 Thousand | 861.38 Thousand | 505.62 Thousand | 635.22 Thousand | 708.08 Thousand | 415.9 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.13 Million | 3.05 Million | 1.49 Million | 1.62 Million | 1.35 Million | 941.19 Thousand |
| Operating Income | -2.99 Million | -2.98 Million | -1.49 Million | -1.62 Million | -1.35 Million | -941.19 Thousand |
| Interest Expense | 8886.00 | 10.13 Thousand | 926.00 | - | - | - |
| Income Tax Expense | -173.08 Thousand | -199.62 Thousand | -65.06 Thousand | -119.95 Thousand | -212.38 Thousand | -97.03 Thousand |
| Earnings before Tax | -3 Million | -2.99 Million | -1.49 Million | -1.62 Million | -1.36 Million | -941.45 Thousand |
| Net Income | -2.83 Million | -2.79 Million | -1.43 Million | -1.5 Million | -1.14 Million | -844.41 Thousand |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 164.71 Million | 156.78 Million | 146.69 Million | 128.42 Million | 122.37 Million | 119.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 164.71 Million | 156.78 Million | 146.69 Million | 128.42 Million | 122.37 Million | 119.02 Million |
| Gross Margin | 0.65 | 0.21 | - | - | - | - |
| EBIT Margin | -22.38 | -39.48 | - | - | - | - |
| Profit Margin | -21.47 | -37.35 | - | - | - | - |
| EBITDA | -2.95 Million | -2.95 Million | -1.49 Million | -1.61 Million | -1.35 Million | 1.00 |
| Earnings Before Tax Margin | -22.71 | -39.87 | - | - | - | - |
| Breakdown | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 | 2021 FY | 2021 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 106.57 Thousand | 132.05 Thousand | 55.07 Thousand | 76.98 Thousand | 74.76 Thousand | 52.81 Thousand |
| Cost of Revenue | 38.35 Thousand | 90.4 Thousand | 49.46 Thousand | 41.59 Thousand | 58.84 Thousand | 35.71 Thousand |
| Gross Profit | 68.22 Thousand | 41.65 Thousand | 5609.00 | 35.38 Thousand | 15.91 Thousand | 17.1 Thousand |
| Operating Expenses | 1.45 Million | 3.04 Million | 1.65 Million | 1.38 Million | 2.99 Million | 1.84 Million |
| Selling, General and Administrative Expenses | 1.2 Million | - | 1.16 Million | 941.89 Thousand | - | 1.37 Million |
| Research and Development Expenses | 247.96 Thousand | - | 486.04 Thousand | 444.58 Thousand | - | 464.68 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.49 Million | 3.13 Million | 1.7 Million | 1.42 Million | 3.05 Million | 1.87 Million |
| Operating Income | -1.38 Million | -2.99 Million | -1.64 Million | -1.35 Million | -2.98 Million | -1.82 Million |
| Interest Expense | 3836.00 | 8886.00 | 4147.00 | 4739.00 | 10.13 Thousand | 4861.00 |
| Income Tax Expense | 55.24 Thousand | -173.08 Thousand | -102.26 Thousand | -70.82 Thousand | -199.62 Thousand | -110.81 Thousand |
| Earnings before Tax | -1.39 Million | -3 Million | -1.65 Million | -1.35 Million | -2.99 Million | -1.82 Million |
| Net Income | -1.33 Million | -2.83 Million | -1.55 Million | -1.28 Million | -2.79 Million | -1.71 Million |
| Earnings Per Share Basic | -0.01 | - | -0.01 | -0.01 | - | -0.01 |
| Earnings Per Share Diluted | -0.01 | - | -0.01 | -0.01 | - | -0.01 |
| Weighted Average Shares Outstanding | 176.88 Million | 164.71 Million | 171.92 Million | 156.78 Million | 156.78 Million | 156.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 176.88 Million | 164.71 Million | 171.92 Million | 156.78 Million | 156.78 Million | 156.78 Million |
| Gross Margin | 0.64 | 0.32 | 0.10 | 0.46 | 0.21 | 0.32 |
| EBIT Margin | -12.78 | - | -29.42 | -17.34 | - | -34.24 |
| Profit Margin | -12.52 | -21.47 | -28.15 | -16.69 | -37.35 | -32.52 |
| EBITDA | -1.36 Million | - | -1.62 Million | -1.33 Million | - | -1.8 Million |
| Earnings Before Tax Margin | -13.01 | -22.71 | -29.93 | -17.55 | -39.87 | -34.53 |
KKPNF
NWPG
SRGZ
6038
PLX
CGS